Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC renter loyalty on $530B rent market with Bilt Mastercard/Wells Fargo; $813M+ total, $10.75B valuation Jul 2025 ($250M General Catalyst/GID) targeting $1B revenue with 20+ travel partners competing with Chase Sapphire.
Bilt Rewards is a New York City-based fintech loyalty platform — backed with $813 million+ in total funding including a $250 million round in July 2025 co-led by General Catalyst and GID at a $10.75 billion valuation, following earlier rounds from Blackstone, Wells Fargo, Mastercard, Invitation Homes, AvalonBay, and others — providing renters with the ability to earn points on rent payments (historically unrewarded by loyalty programs) through the Bilt Mastercard issued with Wells Fargo, redeemable across 20+ airline and hotel loyalty programs, real estate purchases, and fitness classes at 40,000+ merchants. Targeting $1 billion in revenue by Q1 2026, Bilt serves millions of renters through its Bilt Alliance network of major residential landlords. Founded in 2019 by Ankur Jain, with Kenneth Chenault (former American Express CEO) as chair and Roger Goodell (NFL Commissioner) on the board.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.